Convergence of the two pandemics: metabolic syndrome and COVID-19 over last two years
has posed unprecedented challenges to individuals as well as healthcare systems …

Patients with type-2 diabetes (T2D) are more likely to develop severe respiratory tract
infections. Such susceptibility has gained increasing attention since the global spread of …

There is mounting evidence that statin use is beneficial for COVID-19 outcomes. We
performed a systematic review and meta-analysis to evaluate the association between statin …

Lipids perform a series of cellular functions, establishing cell and organelles' boundaries,
organizing signaling platforms, and creating compartments where specific reactions occur …

Objective To determine the association between angiotensin-converting enzyme inhibitors
(ACEIs) or angiotensin II receptor blockers (ARBs) use and coronavirus disease 2019 …

Neutrophils possess a diverse repertoire of pathogen clearance mechanisms, one of which
is the formation of neutrophil extracellular traps (NETs). NETs are complexes of histone …

Background Statins are a commonly used class of drugs, and reports have suggested that
their use may affect COVID‐19 disease severity and mortality risk. Objective The purpose of …

Myopathy is the most common side effect of statins, but it has not been addressed effectively.
In anticipation of its wider use as a small molecule to complement the current COVID-19 …

The global coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2
coronavirus started in March 2020. The conclusions from numerous studies indicate that …

Background: The role of statins among patients with established cardiovascular diseases
(CVDs) who are hospitalized with COVID-19 is still debated. This study aimed at assessing …